Reuters reported that China has approved sales of Nvidia's H200, sending the AI chip giant's shares higher in premarket trade ...

Bridgewater Associates said it is still bullish on Chinese stocks this year, after the local market’s rally helped its ...

Plus, health insurers getting slammed ...

As China’s homegrown artificial intelligence boom enters its second year, investors are piling into shares of companies with ...

Blue skies appear to be ahead for Apple -- with one pesky dark cloud.

Nvidia previously pegged lost China revenue at $8 billion a quarter, and that was for a scaled-down chip Nvidia CEO Jensen Huang recently lamented pressure from both the U.S. and China, which has ...

Chinese authorities have instructed customs agents to ban the entrance of Nvidia's H200 AI chips into the country, according to Reuters.

In 2025, the global luxury goods sector faced a prolonged slowdown, hit by economic headwinds, shifting consumer preferences and geopolitical disruptions, including elevated tariff spillovers from U.S ...

As trading volumes in the retail investor-dominated mainland Chinese stocks surged to record highs this month, one of the big ...

Sagimet Biosciences dropped 9% after Ascletis Pharma’s Phase 3 Denifanstat safety data focused on tolerability, not new efficacy, spurring investor caution. SGMT’s Denifanstat, a first-in-class FASN ...